Lower Hutt, New Zealand

Phillip Martin Rendle




Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2003-2016

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Phillip Martin Rendle

Introduction

Phillip Martin Rendle is a notable inventor based in Lower Hutt, New Zealand. He has made significant contributions to the field of pharmaceuticals through his innovative inventions. With a total of 4 patents, Rendle has focused on developing advanced compounds that enhance the efficacy of active agents in therapeutic applications.

Latest Patents

Rendle's latest patents include groundbreaking inventions such as "Dendrimer scaffolds for pharmaceutical use." This invention pertains to novel dendrimer compounds that can be elaborated to create larger and more complex structures. These compounds can encapsulate active agents, thereby modifying their characteristics for better therapeutic outcomes. Another significant patent is for "Macromolecular compounds having controlled stoichiometry." This invention focuses on macromolecules with controlled functional moiety stoichiometry and topology, which are essential for various applications in the pharmaceutical industry.

Career Highlights

Throughout his career, Rendle has worked with prominent companies such as Starpharma Pty Limited and Industrial Research Limited. His experience in these organizations has allowed him to refine his skills and contribute to the development of innovative pharmaceutical solutions.

Collaborations

Rendle has collaborated with notable individuals in his field, including Guy Yeoman Krippner and Gottfried Lichti. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Phillip Martin Rendle's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of effective therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…